종양 절제 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Tumor Ablation Market size is expected to reach USD 8.98 Billion in 2034 from USD 2.73 Billion (2025) growing at a CAGR of 14.12% during 2026-2034.

The Global Tumor Ablation Market has expanded significantly with advancements in minimally invasive cancer treatments. Technologies such as radiofrequency, microwave, and cryoablation are increasingly used to treat tumors with reduced recovery times. Hospitals are adopting these procedures as safer alternatives to traditional surgery.

Growth drivers include rising cancer incidence rates, technological innovation, and increasing healthcare expenditure. Early diagnosis programs and improved imaging techniques have enhanced procedural success rates. Demand is particularly strong in developed healthcare systems.

Future growth is expected through integration of robotic-assisted ablation and AI-guided imaging. Expanding oncology centers in emerging economies will further support demand. Continuous research and regulatory approvals for advanced devices are anticipated to accelerate market expansion globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Radiofrequency Ablation
• Microwave Ablation
• Cryoablation
• Irreversible Electroporation Ablation
• HIFU
• Other

By Treatment

• Surgical Ablation
• Laparoscopic Ablation
• Percutaneous Ablation

By Application

• Kidney Cancer
• Liver Cancer
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Other

COMPANIES PROFILED

• Medtronic, Boston Scientific Corp, Johnson Johnson Service Inc Ethicon, Inc, AngioDynamics, Bioventus Inc Misonix Inc, EDAP TMS, Chongqing Haifu Medical Technology Co, Ltd, Mermaid Medical, HealthTronics, Inc, HS Hospital Service SpA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TUMOR ABLATION MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Radiofrequency Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Microwave Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cryoablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Irreversible Electroporation Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. HIFU Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TUMOR ABLATION MARKET: BY TREATMENT 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Treatment
• 5.2. Surgical Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Laparoscopic Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Percutaneous Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TUMOR ABLATION MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Kidney Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Liver Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Breast Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Lung Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Prostate Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TUMOR ABLATION MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Technology
  • 7.2.2 By Treatment
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Technology
  • 7.3.2 By Treatment
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Technology
  • 7.4.2 By Treatment
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Technology
  • 7.5.2 By Treatment
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Technology
  • 7.6.2 By Treatment
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TUMOR ABLATION INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Boston Scientific Corp
  • 9.2.3 Johnson & Johnson Service Inc. (Ethicon, Inc.)
  • 9.2.4 AngioDynamics
  • 9.2.5 Bioventus Inc. (Misonix Inc.)
  • 9.2.6 EDAP TMS
  • 9.2.7 Chongqing Haifu Medical Technology Co.Ltd
  • 9.2.8 Mermaid Medical
  • 9.2.9 HealthTronicsInc
  • 9.2.10 H.S. Hospital Service S.P.A